Member Exclusive News

The week in industry: Collaboration launched to develop inhibitor for novel oncology target

This week: Avacta Group (Cambridge, UK) selects their clinical candidate from their Affimer Platform, the FDA grants accelerated approval of Genentech’s (CA, USA) treatment for patients with B-cell lymphoma and partnership announced to give UK SMEs access to novel mass spectrometry technologies.

Thumb untitled design
Jun 13, 2019

Please sign in or register for FREE

No comments yet.